What commercially marketed preparations of selective androgen receptor modulators (SARMs) are available, including their formulations, typical dosing regimens, and regulatory or legal status for human use? | Rounds What commercially marketed preparations of selective androgen receptor modulators (SARMs) are available, including their formulations, typical dosing regimens, and regulatory or legal status for human use? | Rounds
Loading...

What commercially marketed preparations of selective androgen receptor modulators (SARMs) are available, including their formulations, typical dosing regimens, and regulatory or legal status for human use?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2026 · View editorial policy

Selective Androgen Receptor Modulator (SARM) Products Marketed for Human Use

No SARMs are approved by the U.S. Food and Drug Administration (FDA) for any indication for human use as prescription or over-the-counter drugs. FDA enforcement actions and public consumer safety communications state that SARMs marketed as “dietary supplements” or “research use only” are treated as unapproved drugs. [1]; [2]

Common Commercial Formulations Described in U.S. FDA Warning Letters

Marketed SARM products in the U.S. are most commonly presented as oral dosage forms, including capsules, and sometimes as “dietary supplements” (despite regulatory findings that the products do not meet the dietary supplement definition). [2]; [3]

Example vendor-specific marketed products (selected)

  • Titan SARMS LLC
  • LGD-4033 (Ligandrol) marketed as “Ligandrol capsules.” [2]
  • RAD-140 (Testolone) marketed as “RAD140 capsules.” [2]
  • S-4 (Andarine) marketed as “S4 capsules.” [2]
  • YK-11 (Myostatin inhibitor) marketed as “YK11 capsules.” [2]

  • Infantry Labs LLC

  • “The Officer (MK-2866/Ostarine)” marketed as a dietary supplement (FDA found the product to be an unapproved drug). [3]
  • “The Lieutenant (LGD-4033)” marketed as a dietary supplement (FDA found the product to be an unapproved drug). [3]

Typical Dosing Regimens in Commercial Advertising

Provision of dosing regimens for SARMs is not appropriate because these substances are unapproved drugs and dosing information would materially facilitate unsafe use. [1]; [2]

Regulatory Status for Human Use (U.S.)

  • FDA has stated that SARMs are unapproved drugs, including when sold as dietary supplements or “sold for research use only.” [1]
  • FDA warning letters describe SARM-containing products as unapproved new drugs under the Federal Food, Drug, and Cosmetic Act and as violating requirements for approval and adequate directions for use. [2]; [3]
  • FDA warning letters also cite safety concerns from SARMs, including serious liver toxicity and potential cardiovascular risks. [2]; [3]

Regulatory Status Outside the U.S. (Selected)

  • UK Anti-Doping states SARMs sold to the public are unapproved products and have not passed safety assessments required for food or supplement ingredients. UK Anti-Doping: About SARMs
  • U.S. Anti-Doping Agency (USADA) describes SARMs as prohibited in sport and notes there is no FDA-approved medical use for these substances (i.e., they are not authorized pharmaceuticals for human use). USADA substance education: Ostarine

Practical Note on “Commercial Availability”

The presence of a product listing (capsules, “research-grade,” or “dietary supplement” labeling) does not establish legal or clinical legitimacy. FDA enforcement actions document that SARM products marketed online as “research” or “supplements” have been treated as unapproved drugs intended for human use. [2]; [3]

Related Questions